Literature DB >> 13981005

Agranulocytosis associated with sulphasalazine ('Salazopyrin') therapy.

J L THIRKETTLE, K R GOUGH, A E READ.   

Abstract

Entities:  

Keywords:  AGRANULOCYTOSIS; SULFONAMIDES

Mesh：

Substances：

Year:  1963        PMID： 13981005     DOI： 10.1016/s0140-6736(63)92048-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  CONTROLLED TRIAL OF SULPHASALAZINE IN THE TREATMENT OF ULCERATIVE COLITIS.

Authors:  A P DICK; M J GRAYSON; R G CARPENTER; A PETRIE
Journal:  Gut       Date:  1964-10       Impact factor: 23.059

Review 2.  Sulfasalazine. Adverse effects and desensitization.

Authors:  S L Taffet; K M Das
Journal:  Dig Dis Sci       Date:  1983-09       Impact factor: 3.199

3.  Agranulocytosis associated with sulphasalazine therapy.

Authors:  P Cochrane; P Atkins; S Ehsanullah
Journal:  Postgrad Med J       Date:  1973-09       Impact factor: 2.401

4.  Agranulocytosis: a report of 30 cases.

Authors:  H M Pretty; G Gosselin; G Colpron; L A Long
Journal:  Can Med Assoc J       Date:  1965-11-13       Impact factor: 8.262
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.